Literature DB >> 7162359

Met- and leu-enkephalin immuno- and bio-reactivity in human stomach and pancreas.

G E Feurle, V Helmstaedter, U Weber.   

Abstract

Acid extracts of human pancreas and gastric corpus and antral mucosa and muscularis were investigated for the presence of met-enkephalin and leu-enkephalin by radioimmunoassay, Sephadex chromatography and radioreceptor assay. As the assays for leu-enkephalin crossreacted with those for met-enkephalin, only cyanogen bromide-treated samples were used for the determination of leu enkephalin. Met-enkephalin immunoreactivity was destroyed by more than 94% when treated with cyanogen bromide. Serial extract dilutions displaced 125 I labelled met-enkephalin and 125 I leu-enkephalin in the respective enkephalin radioimmunoassay both roughly parallel to the standard curves. Sephadex chromatography of the extracts resulted in elution of met-enkephalin and leu-enkephalin immunoreactivity similar to the size of 3H-met-enkephalin, and these eluates displaced 3H-met-enkephalin from rat brain membranes in an opioid radioreceptor assay. The highest concentration of met-enkephalin and leu-enkephalin immunoreactivity in tissue obtained at surgery was in the mucosa of the body of the stomach. Met- and leu-enkephalin receptor bioreactivity concentrations exceeded immunoreactivity concentrations. These investigations provide evidence of the presence of met-enkephalin- and leu-enkephalin-like substances in human stomach and pancreas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7162359     DOI: 10.1016/0024-3205(82)90062-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  A novel endocrine cell type in the guinea-pig gastric mucosa: cellular source of pro-enkephalin-derived peptides. A histochemical, immunohistochemical, and electron microscopical characterization.

Authors:  Y Cetin
Journal:  Histochemistry       Date:  1990

2.  Plasma leucine enkephalin is increased in liver disease.

Authors:  J R Thornton; M S Losowsky
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

3.  Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.

Authors:  B Ahrén
Journal:  Int J Pancreatol       Date:  1989-09

4.  Mechanism of intragastric nicotine protection against ethanol-induced gastric injury.

Authors:  K Endoh; M Baker; F W Leung
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

5.  Beta-endorphin and lipopolysaccharide interactions with human neutrophils.

Authors:  C O Simpkins; E Tate; S Alailima
Journal:  J Natl Med Assoc       Date:  1988-02       Impact factor: 1.798

Review 6.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

7.  The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.

Authors:  X Z Khawaja; I C Green; J R Thorpe; M A Titheradge
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.